
AWS GraphRAG deployment claims 87% faster drug research
On July 9, 2026, ArtificialIntelligence‑News.com reported that an AWS GraphRAG deployment cut drug research cycles by 87%. That’s a big claim. If accurate, it signals that the right data architecture, not bigger models, is what moves the revenue needle in regulated R&D. What the reported AWS GraphRAG deployment achieved According to ArtificialIntelligence‑News.com, the program ran […]







